Table of Contents
Table of Contents
Introduction
Chapter 1. Adult Neurogenesis in Etiology and Pathogenesis of Alzheimer’s Disease
Chapter 2. Adult Neurogenesis and Aneuploidy in Etiology, Pathogenesis and Pathology of Alzheimer’s Disease
Chapter 3. Adult Neurogenesis, Neural Stem Cells and Alzheimer’s Disease: Developments, Limitations, Problems and Promises
Chapter 4. Oxidative Stress in Adult Neurogenesis and in the Pathogenesis of Alzheimer’s Disease
Chapter 5. Adult Neurogenesis, Neuroinflamation, and Therapeutic Potential of Adult Neural Stem Cells
Chapter 6. Adult Neurogenesis and Drug Therapy
Chapter 7. Neurogenesis and the Effect of Antidepressants
Chapter 8. Neurogenic Drugs and Compounds to Treat CNS Diseases and Disorders
Chapter 9. Patent Evaluation. Thirteen Compounds Promoting Oligodendrocyte Progenitor Cell Differentiation and Remyelination for Treating Multiple Sclerosis: Wo2010054307
Chapter 10. Patent Evaluation. Antibodies against CD20 (Rituximab) for Treating Multiple Sclerosis: US20100233121
Chapter 11. Umbilical Cord Blood and Alpha-3 Fucosyl Transferase-Treated Haematopoietic Stem Cells for Transplantation
Chapter 12. Patent Evaluation. Cell Lines Expressing Mutant FX Proteins to Generate Proteins with Reduced Rate of Fucosylation: Wo2010/141478
Chapter 13. Patent Evaluation. Modulation of GDP-Fucose Level for Generating Proteins with Reduced Rate of Fucosylation (Wo2010141855)
Chapter 14. Patent Evaluation. Chimeric Proteins Comprising the Constant Region of Immunoglobulins for Treating Haemophilia B (WO2005001025)
Chapter 15. Patent Evaluation Parthenogenetically Activated Human Oocytes and Parthenogenetic Embryonic Stem Cells: US20100233143
Chapter 16. Tuberous Sclerosis Complex: A Paradigm for Studying Adult Neurogenesis and Brain Tumors
Chapter 17. Adult Neurogenesis in Alzheimer’s Disease and Therapies
Chapter 18. Indacaterol for the Treatment of Patients with Moderate-to-Severe COPD
Conclusions
Index
